Related Experiment Video
Updated: Jan 24, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway
Zhongxin Feng1,2, Qi Chen2, Mingqiang Ren2
1Department of Hematology, West China School of Medicine/West China Hospital, Sichuan University, Chengdu, China, 3341148215@qq.com.
Introduction:
Acute myeloid leukemia (AML), the hematological malignant tumor with high mortality, is still difficult to treat. CD40L is a type II transmembrane protein, which has been reported to have the potential to inhibit growth of some cancer cells.
Materials And Methods:
In order to determine the role of CD40L on AML-M5 cell line THP-1, we overexpressed CD40L in the cells using a lentiviral vector system (pHBLV-CMVIE-Zs Green-T2A-puro vector); overexpression was confirmed by the detection of green fluorescent protein and CD40L protein expression.
Results:
Cellular apoptosis, proliferation, and cycle assays showed that CD40L could promote the apoptosis of, suppress the proliferation of, and stimulate the arrest of the G1/S phase of THP-1 cells. Finally, the protein expression of P53, Bax/Bcl-2, cyclinD1, PCNA, PTEN, and p-Akt illustrated that CD40L may partly influence cell growth of THP-1 cells through those genes, which was confirmed by immunohistochemistry and a PI3K/Akt activator.
Conclusion:
Taken together, CD40L could inhibit cell growth of THP-1 cells through the PI3K/Akt pathway, indicating that the overexpression of CD40L may be a potential target to treat the AML-M5 disease.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Feedback Inhibition
Cells Coordinate Growth and Proliferation
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Primary and Secondary Growth in Roots and Shoots
Enzyme Inhibition

